Dxy.cn is an online healthcare information-sharing website. It provides patients access to drug information and enables them to connect with physicians, healthcare professionals, and more. It was founded in 2000 and is based in Hangzhou, China.
Expert Collections containing Dxy.cn
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Dxy.cn is included in 2 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest Dxy.cn News
Jun 12, 2023
China online healthcare market is forecasted to reach US$426.39 billion in 2027, experiencing growth at a CAGR of 36.89% during the period spanning from 2023 to 2027. The competitive landscape of the market, along with the company profiles of leading players (Alibaba Group Holding Limited, WeDoctor, Ltd., Miao Health, DXY.cn, JD.com, Inc., and Ping An Good Doctor) are also presented in detail. Growth in China online healthcare market is supported by factors such as aging population, rising health expenditure, support from Chinese government, technical innovations and rising internet penetration. However, the market growth is expected to be restrained by lack of motivation and lack of confidence trust of patients in online health care services. China online healthcare market by type can be segmented as follows: online pharmacy, digital healthcare infrastructure, online enterprise service, online consultation, online consumer healthcare and others. In 2022, the dominant share of China online healthcare market was being held by online pharmacy, followed by digital healthcare infrastructure. China's online pharmaceutical sales (including prescription and OTC pharmaceuticals) are likely to record a strong growth, outpacing the entire pharmaceutical market. China online pharmacy market can be segmented as follows: medical devices, over-the-counter (OTC) drugs, nutrition products, prescription and other. In 2022, the dominant share of China online pharmacy market was being held by medical devices, followed by over-the-counter (OTC) drugs, driven by fewer restrictions from the authorities. The COVID-19 pandemic has largely accelerated the development of online healthcare China. The first quarter of 2020 witnessed rapid surge in both new registered users and daily consultations on major online healthcare platforms. Key Target Audience 3.2 China Online Healthcare Market Forecast by Value 3.3 China Online Healthcare Market Penetration 3.4 China Online Healthcare Market Penetration Forecast 3.5 China Online Healthcare Market by Type 3.5.1 China Online Pharmacy Healthcare Market Forecast by Value 3.5.2 China Digital Healthcare Infrastructure Healthcare Market Forecast by Value 3.5.3 China Online Enterprise Service Healthcare Market Forecast by Value 3.5.4 China Online Consultation Healthcare Market Forecast by Value 3.5.5 China Online Consumer Healthcare Market Forecast by Value 3.6 China Online Healthcare Market by Region 3.7 China Online Pharmacy Market by Segment 3.7.1 China Online Medical Devices Market Forecast by Value 3.7.2 China Online Medical Devices Market Penetration 3.7.3 China Online Over-the-counter (OTC) Drugs Market Forecast by Value 3.7.4 China Online Nutrition Products Market Forecast by Value 3.7.5 China Online Nutrition Products Market Penetration 3.7.6 China Online Prescription Market Forecast by Value 3.7.7 China Online Prescription Market Penetration 3.8 China Internet Hospital by Number 3.9 China Internet Hospital by Initiator 4. Market Dynamics
Dxy.cn Frequently Asked Questions (FAQ)
When was Dxy.cn founded?
Dxy.cn was founded in 2000.
Where is Dxy.cn's headquarters?
Dxy.cn's headquarters is located at 3rd Floor, Building 3, Shangfeng E-Commerce Industry Park, Hangzhou.
What is Dxy.cn's latest funding round?
Dxy.cn's latest funding round is Series E.
How much did Dxy.cn raise?
Dxy.cn raised a total of $672M.
Who are the investors of Dxy.cn?
Investors of Dxy.cn include Tencent, Trustbridge Partners, Hillhouse Capital Management, DCM Ventures and Shunwei Capital Partners.
Who are Dxy.cn's competitors?
Competitors of Dxy.cn include Huaren Health and 5 more.
Compare Dxy.cn to Competitors
Hao Daifu connects major hospitals and grassroots medical institutions to form online "medical associations," enabling patients to enjoy remote expert consultation and local services in combination.
Medlinker is a China-focused mobile platform that allows physicians to social network and communicate with each other. Doctors on the platform can find contacts of each other and discuss treatment measures for specific cases.
We Doctor operates as an online healthcare company. It offers mobile applications for connecting patients and doctors. The company was founded in 2004 and is based in Hangzhou, China.
Docquity is a health tech company that focuses on creating a professional community for healthcare professionals. The company provides a platform where healthcare professionals can exchange ideas, access educational resources, and attend virtual discussions. It primarily serves the healthcare industry. It was founded in 2015 and is based in Singapore.
WeTherapy is a digital platform for the traditional Chinese medicine industry that allows individuals to connect to and engage with product and service providers across the traditional Chinese medicine ecosystem. WeTherapy's platform uses advanced analytics and AI to create individualized health solution bundles based on traditional Chinese Medicine theory to support individuals with the prevention of health issues and restoration to health after a health event.
Justhealth develops artificial intelligence (AI) based healthcare software. The company aims to achieve post-diagnosis disease management and service operations. The company serves chemicals, food, pharmaceutical, and agriculture. It was founded in 2015 and is based in Hangzhou, China.